Literature DB >> 15940440

Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

L Schwachtgen1, M Herrmann, T Georg, P Schwarz, N Marx, A Lindinger.   

Abstract

BACKGROUND: N-terminal brain natriuretic peptide (NT-proBNP) is a neurohormonal substance secreted mainly by the cardiac myocytes of the left ventricle and to a less degree of the left atrium. The releasing mechanism is induced by an increased wall stress on the base of volume or pressure load of the ventricle. The physiologic actions of BNP are prohibition of the sympathetic activity, vasodilatation, natriuresis, diureses and inhibition of the renin-angiotensin system. Because of its high sensitivity and specifity in relation to the left ventricular incompetence, BNP as well as NTproBNP are well accepted markers of ventricular dysfunction. It was the aim of the study to establish reference values of NT-proBNP serum concentrations throughout childhood, in particular in the newborn age group.
METHODS: In a cross sectional study, serum NT-proBNP concentrations were measured by an ElectroChemiLuminescenceImmunoAssay ("ECLIA" Roche) in the umbilical cord blood of 62 healthy full-term neonates and in 222 healthy probands from birth up to the age of 18 years.
RESULTS: The concentration of NT-proBNP in the cord blood samples ranged from 281 to 2595 pg/ml (mean: 818 pg/ml). There was a significant increase in the first days of life followed by a rapid decrease during the first year and a further gradual decrease throughout infancy; beyond the 10(th) year of age normal adult values were approached.
CONCLUSIONS: The knowledge of the normal range of plasma NT-proBNP levels in healthy subjects during childhood serves as a non-invasive marker for differentiation of pathologic conditions such as acute myocarditis, hypertrophic or dilated cardiomyopathy, tachyarrhythmias and pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940440     DOI: 10.1007/s00392-005-0246-x

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  28 in total

1.  Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.

Authors:  P F Downie; S Talwar; I B Squire; J E Davies; D B Barnett; L L Ng
Journal:  Clin Sci (Lond)       Date:  1999-09       Impact factor: 6.124

2.  Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth.

Authors:  Thomas S Mir; Reinhard Laux; Hans Henning Hellwege; Bozena Liedke; Cornelius Heinze; Helmut von Buelow; Stephanie Läer; Jochen Weil
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

Review 3.  Urodilatin: a newly described member of the ANP family.

Authors:  S M Feller; M Gagelmann; W G Forssmann
Journal:  Trends Pharmacol Sci       Date:  1989-03       Impact factor: 14.819

Review 4.  The B-type natriuretic peptide assay: a rapid test for heart failure.

Authors:  W Frank Peacock
Journal:  Cleve Clin J Med       Date:  2002-03       Impact factor: 2.321

5.  A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps).

Authors:  H Schweitz; P Vigne; D Moinier; C Frelin; M Lazdunski
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 6.  B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

Authors:  Peter A McCullough; Torbjørn Omland; Alan S Maisel
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

7.  Immunoreactive renin concentrations in healthy children from birth to adolescence.

Authors:  C Krüger; M Rauh; H G Dörr
Journal:  Clin Chim Acta       Date:  1998-06-08       Impact factor: 3.786

8.  Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations.

Authors:  F D R Hobbs; R C Davis; A K Roalfe; R Hare; M K Davies; J E Kenkre
Journal:  BMJ       Date:  2002-06-22

9.  N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases.

Authors:  A Nir; B Bar-Oz; Z Perles; R Brooks; A Korach; A J J T Rein
Journal:  Acta Paediatr       Date:  2004-05       Impact factor: 2.299

10.  Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children.

Authors:  Manfred Rauh; Andreas Koch
Journal:  Clin Chem       Date:  2003-09       Impact factor: 8.327

View more
  16 in total

1.  N-terminal pro-brain natriuretic peptide as a useful predictor of early surgery in neonates with congenital heart diseases: a prospective observational study.

Authors:  Mika Makimura; Hiroshi Koga
Journal:  Pediatr Cardiol       Date:  2013-07-04       Impact factor: 1.655

Review 2.  NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis.

Authors:  Evangelos Christou; Zoe Iliodromiti; Abraham Pouliakis; Rozeta Sokou; Matina Zantiotou; Chrisa Petropoulou; Theodora Boutsikou; Nicoletta Iacovidou
Journal:  Diagnostics (Basel)       Date:  2022-06-08

Review 3.  NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.

Authors:  Amiram Nir; Angelika Lindinger; Manfred Rauh; Benjamin Bar-Oz; Stephanie Laer; Lynn Schwachtgen; Andreas Koch; Jan Falkenberg; Thomas S Mir
Journal:  Pediatr Cardiol       Date:  2008-07-04       Impact factor: 1.655

Review 4.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 5.  Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?

Authors:  Afif El-Khuffash; Eleanor J Molloy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07       Impact factor: 5.747

6.  Hemodynamic changes in neonates born to mothers with Graves' disease.

Authors:  Takamichi Ishikawa; Hiroki Uchiyama; Satoru Iwashima; Toru Baba; Akira Ohishi; Shigeo Iijima; Hiroaki Itoh
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633

7.  Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study.

Authors:  Isabella Melena; Petter Bjornstad; Michal Schäfer; Kendall S Hunter; Alex J Barker; Amy Baumgartner; Linh Chung; Pattara Wiromrat; Uyen Truong; Jane E B Reusch; Kristen J Nadeau
Journal:  J Diabetes Complications       Date:  2021-02-06       Impact factor: 2.852

8.  The Use of N-Terminal-Pro-BNP in Preterm Infants.

Authors:  Afif El-Khuffash; Eleanor Molloy
Journal:  Int J Pediatr       Date:  2009-12-30

9.  Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age.

Authors:  Hyun Kyung Bae; Do Kyung Lee; Jung Hyun Kwon; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2014-08-25

Review 10.  Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?

Authors:  Nathalie Rosenblatt-Velin; Suzanne Badoux; Lucas Liaudet
Journal:  Stem Cells Int       Date:  2016-01-04       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.